Articles From: Vertex Announces Upcoming Presentations of Data at North American Cystic Fibrosis Conference - October 9 to 11, 2014 to Viacom Inc. to Report Quarterly and Fiscal Year 2014 Financial Results on November 13, 2014


Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that 15 abstracts from its cystic fibrosis (CF) research and development program will be presented at the 28 th Annual North American Cystic Fibrosis Conference (NACFC) in Atlanta, October 9 to 11, 2014.
Sign-up for Vertex Announces Upcoming Presentations of Data at North American Cystic Fibrosis Conference - October 9 to 11, 2014 investment picks
Vertex Energy, Inc. (NASDAQ: VTNR ), an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, announced today its financial results for the second quarter and first half of 2014.
Sign-up for Vertex Energy Announces Second Quarter Revenue Improves 105% From a Year Ago investment picks
Vertex Energy, Inc. (NASDAQ: VTNR ), an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, announced that it will release its financial results for second quarter ended June 30, 2014 on Thursday, August 14, 2014, and management will host a conference call on the same day at 10:00 a.m. EDT.
Sign-up for Vertex Energy to Release Second Quarter 2014 Financial Results on Thursday, August 14, 2014 investment picks
Vertex Energy, Inc. (NASDAQ: VTNR ), an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, will present at the Craig-Hallum Capital Group's 5th Annual Alpha Select Conference.
Sign-up for Vertex Energy Will Present at the Craig-Hallum 5th Annual Alpha Select Conference on September 18, 2014 investment picks
Vertex Energy, Inc. (NASDAQ: VTNR ), an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, announced today that its common stock will be included in the Russell 3000®, Russell 2000®, and Russell Global Indexes, along with other indices, after the reconstitution of Russell Investment Group's family of US Indexes which was completed on June 30, 2014 as described on www.russell.com/indexes .
Sign-up for Vertex Energy, Inc. Added to Russell Global, 2000®, and 3000® Indexes investment picks
Vertex Energy, Inc. (NASDAQ: VTNR ), an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, announced today that it has begun due diligence of Heartland Group Holdings LLC under the terms of a letter of intent which contemplates Vertex acquiring substantially all of the assets of Heartland Group Holdings LLC for approximately $16.5 million, which includes an approximate $8 million dollar earnout achievable during the first 2 years.
Sign-up for Vertex Energy, Inc. Begins Due Diligence Process in Connection With Heartland Group Operations in Anticipation of Potential Acquisition and Enters Into Consulting Agreement With Heartland investment picks
Vertex Energy, Inc. (NASDAQ: VTNR ), an environmental services company that recycles industrial waste streams and off-specification commercial chemical products, announced today that Benjamin Cowart, Chairman and CEO, will present at the GHS 100 Energy Conference at the JW Marriott in Chicago, Illinois on Wednesday, June 25, 2014 at 1:30 pm (Central Time). A webcast of the presentation can be accessed by visiting the Company's website at www.vertexenergy.com .
Sign-up for Vertex Energy, Inc. to Present at GHS 100 Energy Conference investment picks
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it has entered into a licensing agreement with Janssen Pharmaceuticals, Inc. for the worldwide development and commercialization of VX-787, a novel medicine discovered by Vertex for the treatment of influenza.
Sign-up for Vertex Licenses VX-787 to Janssen Pharmaceuticals for the Treatment of Influenza investment picks
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the European Commission has approved KALYDECO™ (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight non-G551D gating mutations in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene.
Sign-up for Vertex Receives European Approval for KALYDECO™ (ivacaftor) in Eight Non-G551D Gating Mutations investment picks
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of KALYDECO™ (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight non-G551D gating mutations in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene.
Sign-up for Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor) in Eight Non-G551D Gating Mutations investment picks
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the quarter ended June 30, 2014.
Sign-up for Vertex Reports Second Quarter 2014 Financial Results and Provides Updates on Key Research and Development Programs investment picks
2014/6/24
NEW YORK (MarketWatch) -- Vertex Pharmaceuticals Inc. (vtrx) on Tuesday announced results from two Phase 3 trials of a cystic fibrosis treatment, which met their primary endpoint compared to placebo.
Sign-up for Vertex reports successful Phase 3 trial of cystic fibrosis treatment investment picks
By Ben Eisen, MarketWatch NEW YORK (MarketWatch) -- Vertex Pharmaceuticals Inc. shares surged in premarket trade Tuesday after successful results of a clinical trial.
Sign-up for Vertex soars on trial success; Walgreen falls investment picks
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for the approval of KALYDECO ® in people with cystic fibrosis (CF) ages 18 and older who have the R117H mutation in the cystic fibrosis transmembrane conductance regulator ( CFTR) gene.
Sign-up for Vertex Submits Supplemental New Drug Application (sNDA) to U.S. Food and Drug Administration for Use of KALYDECO® (ivacaftor) in People 18 and Older with Cystic Fibrosis who have the R117H Mutation investment picks
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its second quarter 2014 financial results on Tuesday, July 29, 2014 after the financial markets close.
Sign-up for Vertex to Announce Second Quarter 2014 Financial Results on July 29 investment picks
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 10 at 8:35 a.m. ET.
Sign-up for Vertex to Present at the Morgan Stanley Global Healthcare Conference on September 10 investment picks
By Anna Prior Vertex Pharmaceuticals Inc. said on Tuesday that an experimental treatment combined with its Kalydeco drug significantly improved lung function for a certain type of cystic fibrosis in a pair of Phase 3 studies.
Sign-up for Vertex' late-stage Cystic Fibrosis trial meets goals investment picks
Vestis Retail Group, LLC (“Vestis”) today announced the successful completion of the cash tender offer (the “Offer”) by it and its wholly owned subsidiary, Everest Merger Sub, Inc. (“Merger Sub”), for all outstanding Class A and Class B shares (the “Shares”) of Sport Chalet, Inc. (NASDAQ: SPCHA)(NASDAQ: SPCHB) at a price of $1.20 per Share, net to the seller in cash (less any required withholding taxes and without interest). Computershare Trust Company, N.A., the depositary for the Offer, has advised Vestis that, as of 12:00 midnight, New York City time, at the end of August 15, 2014 (the “Expiration Date”), approximately 4,178,979 Class A shares and 1,455,923 Class B shares had been validly tendered and not withdrawn in the Offer.
Sign-up for Vestis Retail Group Completes Tender Offer for All Outstanding Shares of Sport Chalet Stock investment picks
VF Corporation (NYSE: VFC) today announced that Dan Cherian has joined the company as Vice President, Global Innovation, Performance Apparel and Footwear.
Sign-up for VF Announces Leadership Appointment to Drive Innovation in Performance Apparel and Footwear investment picks
NEW YORK (MarketWatch) -- Shares of VF Corp.
Sign-up for VF Corp. shares slip in premarket after 2014 profit outlook disappoints investment picks
VF Corporation (NYSE:VFC) today provided a progress update regarding continuing actions to improve the safety and working conditions at its contract suppliers’ manufacturing sites in Bangladesh.
Sign-up for VF Corporation Outlines Progress Made to Improve Bangladesh Worker Safety investment picks
VF Corporation (NYSE: VFC) today reported financial results for its second quarter ended June 28, 2014.
Sign-up for VF Corporation Reports Second Quarter 2014 Results investment picks
VF Corporation (NYSE: VFC) today announced a collaboration with the International Finance Corporation (IFC), a member of the World Bank Group, to provide up to $10 million in financing for building upgrades and fire and safety improvements in vendor factories in Bangladesh.
Sign-up for VF Teams Up with International Finance Corporation to Provide $10 Million for Bangladesh Factory Safety Improvements investment picks
VF Corporation (NYSE: VFC) today announced it will host an investor meeting to highlight its Timberland ® brand on Sept.
Sign-up for VF to Host Timberland Brand Investor Meeting on September 17, 2014 investment picks
2014/7/14
Def Jam Artists Iggy Azalea, Common And BET's Newly Crowned Best New Artist August Alsina Headline Urban Soundtrack Roster That Includes Emeli Sandé, Trey Songz, And Others! August Alsina's "No Love" Launches To Radio July 14th NEW YORK , July 14, 2014 /PRNewswire/ -- Def Jam artists Iggy Azalea, Common and August Alsina headline the all-star musical roster inspired by the hit franchise Love & Hip Hop .
Sign-up for VH1 LOVE & HIP HOP: MUSIC FROM THE SERIES Set For August 19th Release On Def Jam Recordings! investment picks
Viacom (NASDAQ:VIAB)(NASDAQ:VIA) and Sony Corporation (NYSE:SNE) today announced a landmark agreement for Sony’s forthcoming cloud-based TV service to carry 22 Viacom networks at launch.
Sign-up for Viacom and Sony Reach Landmark Internet Distribution Agreement investment picks
Viacom International Media Networks (VIMN), a division of Viacom Inc. (Nasdaq: VIAB, VIA), today announced the completion of its £450M acquisition of Channel 5 Broadcasting Limited from Northern & Shell Media Group.
Sign-up for Viacom Closes Acquisition of Channel 5 investment picks
2014/7/22
Viacom Inc. (NASDAQ: VIAB and VIA) today announced that its Board of Directors has declared a quarterly cash dividend of $0.33 per share on both its Class A and Class B common stock.
Sign-up for Viacom Declares Quarterly Cash Dividend investment picks
ADVISORY, July 28, 2014 (GLOBE NEWSWIRE) -- What: Viacom Inc. (Nasdaq:VIA) & Nickelodeon's iconic Dora character from the brand-new animated educational preschool series "Dora and Friends: Into the City!" will visit the NASDAQ MarketSite in Times Square.
Sign-up for Viacom Inc. (NASDAQ: VIA) & Nickelodeon's "Dora" from "Dora and Friends: Into the City!" to Ring The NASDAQ Stock Market Closing Bell investment picks
2014/9/15
Viacom Inc. (NASDAQ:VIAB and VIA) announced today that on Thursday, November 13, 2014, it will issue financial results for the quarter and fiscal year ending September 30, 2014.
Sign-up for Viacom Inc. to Report Quarterly and Fiscal Year 2014 Financial Results on November 13, 2014 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Vertex Announces Upcoming Presentations of Data at North American Cystic Fibrosis Conference - October 9 to 11, 2014 to Viacom Inc. to Report Quarterly and Fiscal Year 2014 Financial Results on November 13, 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices